featured
Molecular Response and Quality of Life in CML Patients Treated With Intermittent TKIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Molecular Response and Quality of Life in Chronic Myeloid Leukemia Patients Treated With Intermittent TKIs: First Interim Analysis of OPTkIMA Study
Cancer Med 2021 Feb 16;[EPub Ahead of Print], M Malagola, A Iurlo, E Abruzzese, M Bonifacio, F Stagno, G Binotto, M D'Adda, M Lunghi, M Crugnola, ML Ferrari, F Lunghi, F Castagnetti, G Rosti, RM Lemoli, R Sancetta, MR Coppi, MT Corsetti, G Rege Cambrin, A Romano, M Tiribelli, A Russo Rossi, S Russo, L Aprile, L Gandolfi, M Farina, S Bernardi, N Polverelli, AM Roccaro, A De Vivo, M Baccarani, D RussoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.